NCT01261338

Brief Summary

Because of industrial pollution, a large number of people in Anniston, Alabama, have elevated body burdens of the class of compounds known as polychlorinated biphenyls (PCBs). There is evidence that these compounds are associated with risks to health including diabetes. There is also evidence that the consumption of a non-absorbable dietary fat can reduce the level of compounds like PCBs. This clinical trial will test the hypothesis that a non-absorbable dietary fat can reduce the levels of PCBs in subjects in Anniston.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
28

participants targeted

Target at P50-P75 for early_phase_1

Timeline
Completed

Started Dec 2010

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

December 1, 2010

Completed
13 days until next milestone

First Submitted

Initial submission to the registry

December 14, 2010

Completed
2 days until next milestone

First Posted

Study publicly available on registry

December 16, 2010

Completed
1.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 1, 2012

Completed
6 months until next milestone

Study Completion

Last participant's last visit for all outcomes

October 1, 2012

Completed
8 years until next milestone

Results Posted

Study results publicly available

September 14, 2020

Completed
Last Updated

September 14, 2020

Status Verified

December 1, 2016

Enrollment Period

1.3 years

First QC Date

December 14, 2010

Results QC Date

June 13, 2013

Last Update Submit

September 11, 2020

Conditions

Keywords

PCBsOlestra

Outcome Measures

Primary Outcomes (2)

  • Percent Change From Baseline for Total PCB Levels

    The outcome is the percent change in body burden of total PCB's measured over one year. Initially the percent of baseline is calculated as (value at one year / value at baseline) \*100, then this is examined modeling over time as compared to the 100% at baseline.

    one year

  • Rate of Change of Lipid Adjusted PCB Levels

    This is a measure of the change in body burden of PCBs

    One year

Study Arms (2)

olestra

EXPERIMENTAL

Non-absorbable fat administered in the form of 24 potato crisps per day (12 each with mid-day and evening meal) providing approximately 15g/day of olestra.

Drug: olestra

Vegetable oil

PLACEBO COMPARATOR

Absorbable fat administered in the form of 12 potato crisps per day (6 each with mid-day and evening meal) in order to match the caloric intake provided by the crisps with Olestra.

Drug: olestra

Interventions

non-absorbable dietary fat

Also known as: Olean, non absorbable fat, fat substitute
Vegetable oilolestra

Eligibility Criteria

Age21 Years - 75 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Elevated blood level of PCBs

You may not qualify if:

  • Pregnancy
  • Breast-feeding
  • Weight-loss medication
  • Gastrointestinal disease

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

West Anniston Foundation

Anniston, Alabama, 36201, United States

Location

Related Publications (1)

  • Jandacek RJ, Heubi JE, Buckley DD, Khoury JC, Turner WE, Sjodin A, Olson JR, Shelton C, Helms K, Bailey TD, Carter S, Tso P, Pavuk M. Reduction of the body burden of PCBs and DDE by dietary intervention in a randomized trial. J Nutr Biochem. 2014 Apr;25(4):483-8. doi: 10.1016/j.jnutbio.2014.01.002. Epub 2014 Jan 29.

MeSH Terms

Interventions

sucrose polyesterFat Substitutes

Intervention Hierarchy (Ancestors)

Food AdditivesFood IngredientsSpecialty Uses of ChemicalsChemical Actions and UsesFoodDiet, Food, and NutritionPhysiological PhenomenaFood and Beverages

Results Point of Contact

Title
Ronald J. Jandacek, PhD, Principal Investigator
Organization
University of Cincinnati

Study Officials

  • Ronald J Jandacek, Ph.D.

    University of Cincinnati

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
No
Restrictive Agreement
No

Study Design

Study Type
interventional
Phase
early phase 1
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, INVESTIGATOR
Purpose
BASIC SCIENCE
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

December 14, 2010

First Posted

December 16, 2010

Study Start

December 1, 2010

Primary Completion

April 1, 2012

Study Completion

October 1, 2012

Last Updated

September 14, 2020

Results First Posted

September 14, 2020

Record last verified: 2016-12

Data Sharing

IPD Sharing
Will not share

Locations